Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nucleotide-binding oligomerization domain-containing protein 2 | ||
Ligand | BDBM41203 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | SAR analysis of compounds that inhibit NOD2 - Set 3 | ||
IC50 | 1200±n/a nM | ||
Citation | PubChem, PC SAR analysis of compounds that inhibit NOD2 - Set 3 PubChem Bioassay(2010)[AID] | ||
More Info.: | Get all data from this article, Solution Info, Assay Method | ||
Nucleotide-binding oligomerization domain-containing protein 2 | |||
Name: | Nucleotide-binding oligomerization domain-containing protein 2 | ||
Synonyms: | CARD15 | Caspase recruitment domain-containing protein 15 | IBD1 | Inflammatory bowel disease protein 1 | NOD2 | NOD2_HUMAN | Nucleotide-binding oligomerization domain-containing protein 2 | nucleotide-binding oligomerization domain containing 2 | ||
Type: | PROTEIN | ||
Mol. Mass.: | 115287.18 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_1454053 | ||
Residue: | 1040 | ||
Sequence: |
| ||
BDBM41203 | |||
n/a | |||
Name | BDBM41203 | ||
Synonyms: | 2-(1,3-Dimethyl-2,6-dioxo-7-propyl-2,3,6,7-tetrahydro-1H-purin-8-ylsulfanyl)-N-(4,5,6,7-tetrahydro-benzothiazol-2-yl)-acetamide | 2-(1,3-dimethyl-2,6-dioxo-7-propylpurin-8-yl)sulfanyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide | 2-[(1,3-dimethyl-2,6-dioxo-7-propyl-8-purinyl)thio]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide | 2-[(2,6-diketo-1,3-dimethyl-7-propyl-purin-8-yl)thio]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide | 2-[1,3-dimethyl-2,6-bis(oxidanylidene)-7-propyl-purin-8-yl]sulfanyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)ethanamide | MLS000029447 | SMR000002300 | cid_653676 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H24N6O3S2 | ||
Mol. Mass. | 448.562 | ||
SMILES | CCCn1c(SCC(=O)Nc2nc3CCCCc3s2)nc2n(C)c(=O)n(C)c(=O)c12 | ||
Structure |